Therapyte joins NVIDIA Inception

21 November 2022
Therapyte joins NVIDIA Inception

Munich, 11, 2022 — Therapyte today announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technology advancements.

Therapyte is focused on processing multilingual real-world data to generate real-world evidence (RWE) insights for healthcare decision makers. The in-house designed platform can be deployed to overcome challenges related to the access of unstructured medical big data. Therapyte is developing tools and algorithms aimed at collecting and processing real-world data from healthcare facilities combined with AI and analytics for health and clinical research.

NVIDIA Inception will allow Therapyte to scale faster due to access to cutting-edge technology and NVIDIA experts. The program will also offer Therapyte the opportunity to collaborate with industry-leading experts and other AI-driven organizations.

“We are thrilled to become a member of this program and have the chance to work closely with a team of experts and share knowledge with peers. Access to the best technical tools and resources provided by NVIDIA Inception will positively advance our AI solutions and broaden our skills in deep learning and data science to generate valuable insights for product enhancement,” said Ekaterina Krinitsyna, Head of Business Development, Therapyte. “We look forward to a successful collaboration, and we are thankful to NVIDIA’s team for this exciting opportunity.”

NVIDIA Inception helps startups during critical stages of product development, prototyping and deployment. Every NVIDIA Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute credits, marketing support and technology assistance, which provides startups with the fundamental tools to help them grow.